Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.
Marasco M, Kumar D, Garcia Borrego S, Seale T, Maddalena G, Mezzadra R, Belanger K, Cole S, Perez B, Luan W, Mukherjee R, Aricescu I, Markov V, Zhu Y, Arena S, Bardelli A, de Stanchina E, Lowe SW, Burkhart RA, Zimmerman JW, Yaeger R, Kopetz SE, Rosen N, Misale S.
Marasco M, et al. Among authors: markov v.
Cancer Discov. 2025 Jul 3;15(7):1392-1409. doi: 10.1158/2159-8290.CD-24-0614.
Cancer Discov. 2025.
PMID: 40294008